List of Tirosint drug patents

Tirosint is owned by Institut Biochimique.

Tirosint contains Levothyroxine Sodium.

Tirosint has a total of 2 drug patents out of which 0 drug patents have expired.

Tirosint was authorised for market use on 13 October, 2006.

Tirosint is available in capsule;oral dosage forms.

The generics of Tirosint are possible to be released after 14 March, 2024.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7691411 INSTITUT BIOCHIMIQUE Pharmaceutical formulae for thyroid hormones and procedures for obtaining them
Mar, 2024

(1 year, 1 month from now)

US7723390 INSTITUT BIOCHIMIQUE Pharmaceutical formulations for thyroid hormones
Mar, 2024

(1 year, 1 month from now)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 13 October, 2006

Treatment: NA


How can I launch a generic of TIROSINT before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic